Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors - Drug Trials For Money - Paid Clinical Trials

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Conditions: Advanced Solid Tumors; Glioblastoma; Soft Tissue Sarcoma (Excluding GIST); Endometrial Carcinoma; Epithelial Ovarian Carcinoma; Mesothelioma; Gastroenteropancreatic Neuroendocrine Tumor; SCLC; Gastric Carcinoma; Pancreatic Adenocarcinoma; Colorectal Carcinoma; Neuroendocrine Tumors
Interventions: Drug: Lurbinectedin; Drug: Irinotecan
Sponsor: PharmaMar
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 3, 2021 / by ClinicalTrials.gov / in Gastroenterology

Comments